Joseph Jimenez
From Wikipedia, the free encyclopedia
| Joseph Jimenez | |
|---|---|
| Nationality | American |
| Alma mater |
Stanford University University of California, Berkeley[1] |
| Occupation | CEO of Novartis |
Joseph Jimenez is the CEO of the Swiss pharmaceutical company Novartis.[2]
Education
Jimenez earned a bachelor's degree from Stanford University in 1982, and an MBA from University of California, Berkeley in 1984.[3]
Career
Early career
Jimenez began his career at Clorox before joining ConAgra Foods.[4] Prior to joining Novartis, he was head of H. J. Heinz Company's North American business from 2002 to 2006. He was also a non-executive director of AstraZeneca from 2002 to 2007, as well as an advisor for the Blackstone Group.[1]
Novartis
Jimenez joined Novartis in 2007 as Division Head of Novartis Pharmaceutical. and was named CEO in 2010[5] by his predecessor and Chairman Daniel Vasella.[6]
References
- ↑ 1.0 1.1 http://www.novartisfoundation.org/platform/content/element/4381/bio_jimenez_e_final.pdf
- ↑ "Fix the Problem, and Not Just the Symptoms". New York Times. Retrieved 22 May 2013.
- ↑ "Joseph Jimenez MBA". Businessweek. Retrieved 22 May 2013.
- ↑ "Joseph Jimenez - Forbes". People.forbes.com. 2012-04-18. Retrieved 2012-08-02.
- ↑ "Joseph Jimenez - The 25 most influential people in biopharma today". Fierce Biotech. Retrieved 22 May 2013.
- ↑ Greil, Anita (2010-01-26). "Vasella’s Impeccable Timing - The Source - WSJ". Blogs.wsj.com. Retrieved 2012-08-02.
External links
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.